发明名称 USE OF HYDROXYGUANIDINES
摘要 <p>Hydroxyguanidines are useful for the manufacture of a medicament for treatment or prevention of an ischemic disease condition including an ischemic condition caused by surgery or other therapy and being associated with the production of oxygen derived radicals, the disease condition being a xanthine oxidase/xanthine dehydrogenase mediated ischemic condition selected from heart infarction, angina pectoris, cerebrovascular infarction, circulatory shock, transient ischemic attacks of the cerebrovascular system, arterial occlusion, arterial thromboembolism, bowel torsion with strangulation, testicular torsion, lung embolus, cardiac surgery including by-pass grafting, and localised organ surgery involving reduced blood flow, organ transplantation, circulatory shock, and general hypoxia. Preferred hydroxyguanidines are carbimino hydroxyguanidines, in particular aryl carbimino hydroxyguanidines. Also disclosed are corresponding methods of treatment, including extracorporeal treatment of organs, and a number of hydroxyguanidines.</p>
申请公布号 WO9823267(A1) 申请公布日期 1998.06.04
申请号 WO1997SE01969 申请日期 1997.11.21
申请人 WAPHARM AB;WIKBERG, JARL;PRUSIS, PETERIS;DAMBROVA, MAIJA;UHLEN, STAFFAN 发明人 WIKBERG, JARL;PRUSIS, PETERIS;DAMBROVA, MAIJA;UHLEN, STAFFAN
分类号 A01N1/02;A61K31/155;A61K31/341;A61K31/352;A61K31/381;A61K31/40;A61K31/404;A61K31/415;A61K31/4196;A61K31/426;A61K31/44;A61K31/4409;A61P9/00;A61P9/06;A61P43/00;C07C281/18;C07D207/32;C07D207/335;C07D213/61;C07D213/89;C07D231/16;C07D249/14;C07D277/28;C07D307/52;C07D311/22;C07D311/24;C07D333/22;C07D333/58;(IPC1-7):A61K31/155;C07D213/42;C07C281/16;A61K31/045 主分类号 A01N1/02
代理机构 代理人
主权项
地址